Amicus Therapeutics, Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

14.37

+0.04 (0.28%)

At close: Feb 27, 2026, 4:00 PM EST

14.35

-0.02 (-0.14%)

After-hours: Feb 27, 2026, 6:15 PM EST

Amicus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-27.11	-56.11	-151.58	-236.57	-250.46
Depreciation & Amortization	7.46	8.55	7.87	5.34	6.21
Other Amortization	2.57	2.26	2.62	2.63	2.49
Asset Writedown & Restructuring Costs	-1.14	9.21	2.73	18.18	-
Stock-Based Compensation	87.41	84.91	86.08	76.51	57.84
Other Operating Activities	3.59	16.23	31.19	7.21	10.37
Change in Accounts Receivable	-5.86	-19.48	-20.11	-17.33	-8.19
Change in Inventory	-111.48	-73.65	-44.61	-5.34	-7.79
Change in Accounts Payable	82.78	-16.52	49.2	-6.38	7.43
Change in Other Net Operating Assets	-5.07	10.71	-32.46	-10.83	-20.39
Operating Cash Flow	33.15	-33.89	-69.09	-166.58	-202.49
Capital Expenditures	-3.3	-3.55	-7.44	-3.77	-3.88
Sale of Property, Plant & Equipment	-	-	-	3.41	-
Investment in Securities	-43.14	2.99	105.5	92.67	82.65
Investing Cash Flow	-46.43	-0.56	98.06	92.32	78.76
Long-Term Debt Issued	-	-	387.36	-	-
Long-Term Debt Repaid	-0.27	-0.1	-408.32	-0.28	-0.48
Net Debt Issued (Repaid)	-0.27	-0.1	-20.96	-0.28	-0.48
Issuance of Common Stock	19.21	27.24	103.21	4.31	229.21
Repurchase of Common Stock	-18.32	-22.03	-17.92	-11.49	-15.01
Other Financing Activities	-	-	-2.65	-	-1.65
Financing Cash Flow	0.61	5.12	61.68	-7.46	212.07
Foreign Exchange Rate Adjustments	13.28	-4.03	6.31	-14.62	-5.05
Net Cash Flow	0.6	-33.36	96.96	-96.34	83.29
Free Cash Flow	29.85	-37.44	-76.53	-170.34	-206.38
Free Cash Flow Margin	4.71%	-7.09%	-19.16%	-51.74%	-67.55%
Free Cash Flow Per Share	0.10	-0.12	-0.26	-0.59	-0.76
Cash Interest Paid	43.61	58.96	36.09	34.36	30.47
Cash Income Tax Paid	14.89	8.21	8.53	1.61	20.03
Levered Free Cash Flow	47.84	5.41	-25.89	-94.23	-84.97
Unlevered Free Cash Flow	74.12	34.14	2.84	-73.66	-67.16
Change in Working Capital	-39.63	-98.94	-47.99	-39.88	-28.94

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q